Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
5,055
Views
24
CrossRef citations to date
0
Altmetric
Coronaviruses
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
Su-Yeon Yua Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0001-5488-5068View further author information
, Dae-Hyup Koha Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0003-2720-4006View further author information
, Miyoung Choia Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0002-2424-9965View further author information
, Seungeun Ryooa Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Koreahttps://orcid.org/0000-0002-0604-5141View further author information
, Kyungmin Huhb Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Koreahttps://orcid.org/0000-0002-5140-3964View further author information
, Joon Sup Yeomc Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Koreahttps://orcid.org/0000-0001-8940-7170View further author information
& Young Kyung Yoond Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0001-8435-935XView further author information
show allhttps://orcid.org/0000-0001-8435-935XView further author information
Pages 1154-1165
|
Received 19 Jan 2022, Accepted 25 Mar 2022, Published online: 18 Apr 2022
Related Research Data
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.